Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00038116 · ClinicalTrials.gov registry record · Phase 3
Embryonic Dopamine Cell Implants for Parkinson's Disease
A Phase 3 study of Parkinson Disease, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 3
- Development phase
- 40
- Enrollment target
- 3
- Study locations
NCT00038116: Completed Phase 3 study of Parkinson Disease, sponsored by University of Colorado, Denver.
NCT00038116 is a Phase 3 study of Parkinson Disease that has completed, run by University of Colorado, Denver. The registered enrollment target is 40 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00038116, a Phase 3 study of Parkinson Disease, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 40 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this trial is to determine if patients who received embryonic dopamine cell implant surgery showed significantly greater improvement in their Parkinson's disease than a control group undergoing the placebo treatment, and to determine if the cell implant surgery was more effective in younger or older patients.
Conditions Studied
Interventions
- PROCEDURE embryonic dopamine cell implant surgery
- PROCEDURE placebo
Study Locations (3)
New York
- North Shore University Hospital - Manhasset
- The Movement Disorder Center, Columbia-Presbyterian Hospital - New York
Colorado
- University Hospital, the University of Colorado Health Sciences Center - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 1995-05 |
| Est. Completion | 2009-08 |
| Phase | Phase 3 |
What the finished NCT00038116 record still lists
NCT00038116 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which embryonic dopamine cell implant surgery is the first listed.
NCT00038116 reports a single indexed study location in New York, Colorado.
Frequently Asked Questions
What is clinical trial NCT00038116 about?
NCT00038116 is a clinical study titled "Embryonic Dopamine Cell Implants for Parkinson's Disease". The purpose of this trial is to determine if patients who received embryonic dopamine cell implant surgery showed significantly greater improvement in their Parkinson's disease than a control group undergoing the placebo treatment, and to determine if the cell implant surgery was more effective in y...
What is the current status of trial NCT00038116?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 40 participants. The study started on 1995-05. Estimated completion is 2009-08.
What conditions does trial NCT00038116 study?
This clinical trial studies the following conditions: Parkinson Disease.
What interventions are being tested in trial NCT00038116?
The interventions under investigation include: embryonic dopamine cell implant surgery (PROCEDURE), placebo (PROCEDURE).
Who is sponsoring clinical trial NCT00038116?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00038116 being conducted?
This trial has 3 study locations across Colorado, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00038116's enrollment target sits among peer trials
40 173rd of 297 higher than 109 of 297 other Parkinson Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Parkinson Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications
RECRUITING · Phase 3
-
A Digital Therapeutic Platform for Swallowing and Drooling Problems in Parkinson's
RECRUITING · Phase 3
-
A Phase 3 Study With P2B001 in Subjects With Early Parkinson's
COMPLETED · Phase 3
-
An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease
COMPLETED · Phase 3
-
Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson Disease
COMPLETED · Phase 3
-
Flexible-Dose Trial in Early Parkinson's Disease (PD)
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia